Heron Therapeutics | HRTX - Passivo Circulante





Passivo Circulante Alterar Data
ALKERMES USD 662.09M 62.59M 2026-06
Alnylam Pharmaceuticals USD 1.51B 163.04M 2026-06
Amarin USD 164.2M 15.45M 2026-06
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Anika Therapeutics USD 22.15M 1.18M 2026-06
Arrowhead Research USD 283.35M 11.87M 2026-06
Eisai JPY 393.64B 53.39B 2026-06
Emergent BioSolutions USD 651.3M 12.7M 2023-12
GlaxoSmithKline GBP 21.53B 895M 2026-06
Heron Therapeutics USD 92.14M 1.63M 2026-06
Insmed USD 438.74M 77.74M 2026-06
Ligand Pharmaceuticals USD 46.74M 6.07M 2026-06
Merck USD 27.73B 786M 2026-06
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Neurocrine Biosciences USD 874.5M 42.8M 2026-06
Omeros USD 85.5M 2.28M 2025-06
Pacira USD 122.01M 13.22M 2026-06
Regeneron Pharmaceuticals USD 5.53B 422.9M 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Ultragenyx Pharmaceutical USD 351M 26M 2026-06
Veracyte USD 62.74M 6.62M 2026-06
Vertex Pharmaceuticals USD 3.94B 57.3M 2026-06